NEW YORK, NY / ACCESSWIRE / April 20, 2022 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Cerence Inc. (NASDAQ:CRNC)
Class Period: February 8, 2021 - February 4, 2022
Lead Plaintiff Deadline: April 26, 2022
During the class period, Cerence Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the global semiconductor shortage had a materially negative impact on demand for Cerence's software licenses; (2) defendants masked the impact of the semiconductor shortage on demand for the Company's software licenses by pulling forward sales; and (3) as a result of the above, defendants' statements about Cerence's business, operations, and prospects were false and misleading and/or lacked a reasonable basis.
Learn about your recoverable losses in CRNC: https://www.kleinstocklaw.com/pslra-1/cerence-inc-loss-submission-form?id=26186&from=1
Celsius Holdings, Inc. (NASDAQ:CELH)
Class Period: August 12, 2021 - March 1, 2022
Lead Plaintiff Deadline: May 16, 2022
The CELH lawsuit alleges Celsius Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) the Company had improperly recorded expenses for non-cash share-based compensation for second and third quarters of 2021; (2) as a result, the Company's financial statements for those periods would be restated, including to report a net loss for the third quarter of 2021; (3) there was a material weakness in Celsius's internal controls over financial reporting; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Learn about your recoverable losses in CELH: https://www.kleinstocklaw.com/pslra-1/celsius-holdings-inc-loss-submission-form?id=26186&from=1
AbbVie Inc. (NYSE:ABBV)
Class Period: April 30, 2021 - August 31, 2021
Lead Plaintiff Deadline: June 6, 2022
Throughout the class period, AbbVie Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) safety concerns about Pfizer Inc.'s drug Xeljanz extended to Abbvie's drug Rinvoq and to other Janus kinase enzyme inhibitor drugs; (2) as a result, it was likely that the U.S. Food and Drug Administration would require additional safety warnings for Rinvoq and would delay the approval of additional treatment indications for Rinvoq; and (3) therefore, defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis.
Learn about your recoverable losses in ABBV: https://www.kleinstocklaw.com/pslra-1/abbvie-inc-loss-submission-form-2?id=26186&from=1
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
SOURCE: The Klein Law Firm